Recently, recurrent mutations of the Mediator Complex Subunit 12 gene (MED12) have been identified in 70%, 58.8%, 67,6% and 52.2% of LM [17], [21]–[22], [27]. This evidence concerns the gene MED12 and lymphangioma.